Welcome to our dedicated page for Fabrinet SEC filings (Ticker: FN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Fabrinet filings document the company’s operating results, financial condition, governance matters and shareholder actions as a Cayman Islands registrant listed under the FN symbol. Its Form 8-K reports furnish quarterly and annual financial results press releases and also record material governance events, including board appointments, director retirements and executive incentive compensation arrangements.
Proxy materials and annual meeting reports disclose board elections, auditor ratification, advisory executive compensation votes, ordinary-share voting results and meeting procedures. Together, these filings provide formal records of Fabrinet’s manufacturing-services business disclosures, capital and shareholder structure, compensation oversight and public-company governance.
Fabrinet director Thomas F. Kelly reported recent transactions in the company’s ordinary shares. On 12/04/2025, he sold 2,200 ordinary shares at a weighted average price of $464.142 per share, leaving him with 18,789 shares immediately after that sale. The sale price reflects individual trades executed between $464.12 and $464.24 per share. On 12/05/2025, he reported a gift of 25 shares, after which he beneficially owned 18,764 ordinary shares, all held directly. The transactions were disclosed on a Form 4 filed for a single reporting person in his capacity as a director of Fabrinet.
Fabrinet insider files notice to sell ordinary shares under Rule 144. A holder plans to sell 500 ordinary shares through Citigroup Global Markets on the NYSE, with an aggregate market value of $241,000. The filing states that 35,827,210 ordinary shares were outstanding at the time of the notice, providing context for the planned sale.
The seller previously disposed of additional ordinary shares over the past three months, including 479 shares on 09/05/2025 for gross proceeds of $175,314 and 500 shares on 12/04/2025 for gross proceeds of $236,000. The shares to be sold were originally acquired from Fabrinet as restricted stock that vested on 01/02/2023 in exchange for services rendered.
Fabrinet director Darlene S. Knight reported an open-market sale of company stock. On 12/04/2025, she sold 500 ordinary shares of Fabrinet at a price of $472 per share, according to a Form 4 filing. After this transaction, she beneficially owns 3,184 ordinary shares, held in direct ownership.
Fabrinet director reports small share disposition
A Fabrinet director reported a transaction involving the company’s ordinary shares. On 12/03/2025, the reporting person disposed of 70 ordinary shares at a reported price of $0 under transaction code "G". Following this transaction, the director beneficially owns 14,131 ordinary shares, held directly. No derivative securities transactions were reported.
FN filed a notice of proposed sale of restricted shares under Rule 144. The seller plans to sell 2,200 shares of common stock through Morgan Stanley Smith Barney LLC on or around 12/04/2025 on the NYSE. These shares have an aggregate market value of $1,021,111.30 based on the pricing used in the notice, compared with 35,827,210 shares of the issuer’s stock outstanding. The securities were originally acquired on 01/01/2016 as restricted stock vesting under a registered plan in payment for services rendered.
Fabrinet insider plans modest share sale under Rule 144. A holder intends to sell 500 Ordinary Shares of Fabrinet on the NYSE through Citigroup Global Markets, Inc. The shares have an aggregate market value of $236,000 based on the figures disclosed, with 35,827,210 Ordinary Shares shown as outstanding.
The 500 shares were originally acquired from Fabrinet on 01/02/2023 through restricted stock vesting in exchange for services rendered. The approximate sale date indicated is 12/04/2025 and the planned venue is the NYSE.
Over the past three months, Darlene S. Knight has already sold 479 Ordinary Shares of Fabrinet for gross proceeds of $175,314. By signing the notice, the seller represents they are not aware of any undisclosed material adverse information about Fabrinet’s current or prospective operations.
Fabrinet director reports sale of ordinary shares
A Fabrinet director reported selling 3,500 ordinary shares of the company on 12/01/2025. The transaction was coded as a sale and executed at a weighted average price of $453.747 per share, with individual trade prices ranging from $453.71 to $454.15 per share. After this transaction, the reporting person holds 18,316 Fabrinet ordinary shares, owned directly.
Fabrinet insider files Form 144 to sell ordinary shares. A holder has notified regulators of an intention to sell 3,500 ordinary shares of Fabrinet through Citigroup Global Markets on the NYSE. The planned sale, dated 12/01/2025, is based on an aggregate market value of $1,588,115 as reported in the notice.
The shares were acquired on 12/01/2025 via restricted stock vesting from Fabrinet as consideration for services rendered. Shares outstanding were 35,827,210 at the time of the notice; this is a baseline figure, not the amount being sold. By signing, the seller represents they are not aware of undisclosed material adverse information about Fabrinet’s current or prospective operations.
Fabrinet (FN) shareholder has filed a Form 144 to sell up to 22,451 ordinary shares. The planned sale is to be executed through Citigroup Global Markets, Inc. on the NYSE around 11/26/2025, with an indicated aggregate market value of $10,123,604.92. These shares relate to restricted stock that vested on 11/26/2025 as compensation in the form of services rendered.
The notice also reports earlier activity: over the past three months, the same seller disposed of 9,513 ordinary shares for gross proceeds of $3,134,730.00. The filing states that the seller is not aware of any undisclosed material adverse information about Fabrinet’s current or prospective operations.
FMR LLC filed a Schedule 13G/A (Amendment No. 1) on Fabrinet (FN), reporting beneficial ownership of 2,327,329.49 shares of common stock, representing 6.5% of the class as of 09/30/2025.
FMR reports sole voting power over 2,320,712.00 shares and sole dispositive power over 2,327,329.49 shares, with no shared voting or dispositive power. Abigail P. Johnson is also a reporting person, with sole dispositive power over 2,327,329.49 shares. The certification states the securities were acquired and are held in the ordinary course and not to change or influence control.